Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Squamous cell carcinoma of head and neck

Recruiting

Registered drug

Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Systemic lupus erythematosus

Recruiting

Registered drug

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drugNo placebo

Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Hepatic fibrosis+2

Recruiting

Investigational

Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Efruxifermin

Contact Research Centre

Sjogren's syndrome

Recruiting

Investigational

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Deucravacitinib

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Arteriosclerosis

Recruiting

Investigational

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Clazakizumab

Contact Research Centre

Hepatic cirrhosis+2

Recruiting

Investigational

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Efruxifermin

Contact Research Centre

Influenza+1

Recruiting

Registered drugNo placebo

Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

Registered drugNo placebo

Spain

Participants:65+ years · Healthy volunteers
Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED

Contact Research Centre

Transitional cell carcinoma

Recruiting

Registered drugNo placebo

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Durvalumab

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Find therapies in clinical trials near you – page 3

599 trials match your criteria

Squamous cell carcinoma of head and neck

Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

Systemic lupus erythematosus

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Neoplasm malignant

Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

Colorectal cancer metastatic

Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer

Hepatic fibrosis+2

Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Sjogren's syndrome

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Neoplasm malignant

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Arteriosclerosis

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Hepatic cirrhosis+2

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Influenza+1

Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

Transitional cell carcinoma

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Type 2 diabetes mellitus

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.